Dry Eye Tear Film Composition With Nano-Micellar Moisture Lock

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current artificial tear compositions fail to provide a long-lasting evaporative shield, cause blurred vision, and are uncomfortable due to high viscosity or synthetic oily sensations, while also failing to dissolve lipid deposits and promote natural tear secretion effectively.

Innovation Solution

Formulations comprising nonionic surfactants like polysorbates, poloxamers, and viscosity enhancers such as cellulose derivatives, along with polyols and electrolytes, create a nano-micellar layer that stabilizes the tear film layers and seals in natural tears, reducing evaporation and promoting secretion without toxicity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If high viscosity artificial tear compositions are used to maintain longer lasting tear film, then duration of action is improved, but ease of operation deteriorates due to blurred vision and sticky sensation

Engineering Contradiction:
Improveduration of tear film maintenanceVSAvoidcomfort during blinking
Core Design Contradiction:
Duration of action of moving objectVSEase of operation

Solution Approach 1:

The patent applies non-Newtonian fluid mechanics by using hydroxypropyl methyl cellulose as a viscosity modifier that creates shear-thinning behavior. The composition maintains high viscosity at rest for prolonged tear film coverage but reduces viscosity during blinking motion, eliminating blurred vision and sticky sensations while preserving duration of action.

Inventive Principle:
Principle #15Dynamics

2Loss of substance

If lipids are added to create evaporative shield, then loss of substance is reduced, but object-generated harmful factors increase due to synthetic oily sensation

Engineering Contradiction:
Improvetear evaporationVSAvoidsynthetic oily sensation
Core Design Contradiction:
Loss of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical composition parameters by replacing synthetic lipids with natural tear film components including bovine serum albumin and recombining human epidermal growth factor. This creates an evaporative shield through protein-based mechanisms rather than lipid-based ones, eliminating synthetic oily sensation while maintaining tear retention.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If surfactant concentration is increased above 1% to dissolve lipid deposits, then cleaning effectiveness is improved, but object-affected harmful factors increase due to surfactant toxicity

Engineering Contradiction:
Improvelipid deposit dissolutionVSAvoidsurfactant toxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent creates a composite surfactant system combining multiple nonionic surfactants (polysorbate 20, polysorbate 80, poloxamer 188, poloxamer 407, polyoxyl 30 castor oil, polyoxyl 40 hydrogenated castor oil) in specific ratios. This composite approach enhances lipid dissolution capability while the synergistic interaction reduces individual surfactant toxicity, allowing effective concentrations without harmful effects.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent introduces viscosity-modifying agents (hydroxypropyl methyl cellulose, carboxymethyl cellulose sodium, carbomer 940) as intermediaries that work with the surfactant system. These intermediaries enhance the overall cleaning effectiveness and stabilize the composition, allowing reduced surfactant concentrations while maintaining lipid deposit dissolution capability.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Reliability

If preservatives are used to reduce infection risk, then reliability is improved, but object-generated harmful factors increase due to preservative toxicity

Engineering Contradiction:
Improveinfection preventionVSAvoidpreservative toxicity
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and eliminates traditional preservative systems (benzalkonium chloride, thimerosal, parabens) from the composition. Instead, it relies on the inherent antimicrobial properties of the surfactant system and the sterile manufacturing process to prevent infection, removing preservative-induced toxicity while maintaining reliability.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compositions offer a prolonged Moisture-Lock™ effect, maintaining tear film stability with minimal blur and discomfort, enhancing natural tear exposure and promoting healing, while dissolving lipid deposits and reducing preservative toxicity.

Implementation Method 1

Formulations comprising nonionic surfactants like polysorbates, poloxamers, and viscosity enhancers such as cellulose derivatives, along with polyols and electrolytes, create a nano-micellar layer that stabilizes the tear film layers and seals in natural tears, reducing evaporation

Methodology Applied
Scientific EffectMicelle formation: Surfactant

Implementation Method 2

viscosity enhancers such as cellulose derivatives... provide a viscosity of from about 50 to about 10,000 centipoise at 0 shear to 1 second

Methodology Applied
Scientific EffectViscosity enhancement:

Implementation Method 3

a pH from about 5 to about 6, an osmolarity of from about 350 to about 550 milliosmoles

Methodology Applied
Scientific EffectOsmotic pressure: Osmotic Pressure

Implementation Method 4

a means for inducing tears... wherein the means for inducing tears comprises a pH from about 5 to about 6, an osmolarity of from about 350 to about 550 milliosmoles

Methodology Applied
Scientific EffectTear induction:

Implementation Method 5

a means for sequestering tears... wherein the means for sequestering tears comprises from about 1.5% to about 5.9% w/v total volume of one or more nonionic surfactants and one or more viscosity enhancers

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentUS20250367297A1Ophthalmological compositions and methods of use thereof
Publication Date: 2025.12.04 PS THERAPY INC
  • US20250367297A1 patent drawing
  • US20250367297A1 patent drawing
  • US20250367297A1 patent drawing

AI summary

The invention is directed to compositions comprising one or more polysorbates, one or more poloxamers, one or more cyclodextrins, one or more polyoxyl castor oils, one or more polyethylene glycols, one or more polyols, one or more cellulose derivatives and menthol. The invention is further directed to a method of treating dry eye comprising topically applying compositions of the present invention to the eye of a subject in need thereof.